This vial contains CJC-1295 + Ipamorelin supplied at a strength or concentration of 9 mg / 15 mg and is manufactured in a 503B FDA-registered outsourcing facility in accordance with high quality standards. This product is intended for use by qualified healthcare providers in a clinical setting.